10-K: Astrana Health, Inc. Outlines Share Structure and Governance in SEC Filing

Astrana Health, Inc. details its common and preferred stock structure, voting rights, dividend policies, and anti-takeover provisions in a recent SEC filing.

Summary

• Astrana Health, Inc. has authorized 100,000,000 shares of common stock and 5,000,000 shares of preferred stock, each with a par value of $0.001.
• Holders of common stock are entitled to one vote per share and do not have cumulative voting rights.
• Common stockholders are entitled to receive dividends as declared by the board of directors, subject to the rights of preferred stockholders.
• In the event of liquidation, common stockholders will share ratably in net assets after payment of debts and satisfaction of preferred stock liquidation preferences.
• The company has designated 1,111,111 shares as Series A convertible preferred stock and 555,555 shares as Series B convertible preferred stock.
• All outstanding shares of common stock are duly authorized, fully paid, and non-assessable.
• Holders of common stock have no preemptive, conversion, subscription, or other rights, and there are no redemption or sinking fund provisions applicable to the common stock.
• The rights of common stockholders may be adversely affected by the rights of preferred stockholders.
• The common stock is listed on The Nasdaq Stock Market LLC under the trading symbol ASTH.
• Certain outstanding shares of common stock have registration rights.
• The transfer agent for the common stock is Pacific Stock Transfer, a Securitize company.
• The board of directors is authorized to issue up to 5,000,000 shares of preferred stock in one or more series, with the power to fix the designation, powers, preferences, and rights of each series.
• The issuance of preferred stock could adversely affect the voting power of common stockholders and the likelihood of receiving dividend payments and payments upon liquidation.
• The company has 1,666,666 shares of preferred stock designated and issued, consisting of 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock, all of which are held by Astrana Health Management, Inc., a wholly-owned subsidiary.
• The Series A and Series B preferred stock have an initial liquidation preference of $9.00 per share, plus any declared and unpaid dividends, and are convertible into common stock at a one-for-one initial conversion rate.
• The Certificate of Incorporation and Bylaws contain anti-takeover provisions that could delay or discourage a change of control.
• The company is subject to Section 203 of the Delaware General Corporation Law, which generally prohibits a business combination with an interested stockholder for a period of three years after the date of the transaction in which the person became an interested stockholder unless certain conditions are met.
• The company's authorized and unissued shares of common stock are available for future issuance without stockholder approval, except as may be required by applicable regulations or Delaware law.

Sentiment

Score: 6

Explanation: The document is neutral in tone, providing factual information about the company's share structure and governance. It does not express any positive or negative sentiment, but rather outlines the terms and conditions of the company's securities.

Positives

• The company has a clear structure for its common and preferred stock.
• The company has the flexibility to issue additional shares for various purposes.
• The company has a transfer agent in place for its common stock.

Negatives

• The rights of common stockholders may be adversely affected by the rights of preferred stockholders.
• The company's anti-takeover provisions could discourage potential acquirers.
• The company's authorized but unissued shares could make it more difficult to obtain control of the company.

Risks

• The issuance of preferred stock could dilute the voting power of common stockholders.
• The issuance of preferred stock could reduce the likelihood of common stockholders receiving dividend payments and payments upon liquidation.
• The anti-takeover provisions could delay or prevent a change of control of the company.
• The company's authorized but unissued shares could discourage an attempt to obtain control of the company.

Future Outlook

The company may issue additional shares for a variety of purposes, including future offerings to raise additional capital, to fund acquisitions and as employee, director and consultant compensation.

Industry Context

This document provides insight into the capital structure and governance of a publicly traded healthcare company, which is relevant to understanding its financial position and potential for future growth or acquisition.

Comparison to Industry Standards

• The dual-class stock structure with common and preferred shares is a common practice among publicly traded companies, particularly in the technology and healthcare sectors.
• The anti-takeover provisions are also common, as they are designed to protect the company from hostile takeovers.
• The specific terms of the preferred stock, such as the liquidation preference and conversion rate, are typical for this type of security.
• The company's authorized but unissued shares are also common, as they provide flexibility for future capital raises and acquisitions.
• Comparable companies with similar capital structures and anti-takeover provisions include companies such as Google (Alphabet Inc.) and Facebook (Meta Platforms, Inc.).

Corporate Governance

Stakeholder Impact

• Shareholders: The document outlines the rights and preferences of common and preferred stockholders, which is important for understanding their potential returns and risks.
• Potential Acquirers: The anti-takeover provisions could make it more difficult for a potential acquirer to take over the company.
• Employees: The document mentions that the company may issue additional shares as employee compensation, which could impact employee benefits.

Next Steps

• The company may issue additional shares for a variety of purposes, including future offerings to raise additional capital, to fund acquisitions and as employee, director and consultant compensation.

Keywords

common stock, preferred stock, voting rights, dividends, liquidation, anti-takeover provisions, Delaware General Corporation Law, Nasdaq, registration rights, transfer agent